+44 1478 350008Pancreatic Disorders & Therapy : Citations & Metrics Report
Articles published in Pancreatic Disorders & Therapy have been cited by esteemed scholars and scientists all around the world. Pancreatic Disorders & Therapy has got h-index 11, which means every article in Pancreatic Disorders & Therapy has got 11 average citations.
Following are the list of articles that have cited the articles published in Pancreatic Disorders & Therapy.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
40 | 50 | 25 | 28 | 9 | 1 | 7 | 11 | 21 | 35 | 20 | 33 | 30 | 5 |
Research, Review articles and Editorials |
1 | 0 | 2 | 3 | 7 | 1 | 5 | 5 | 16 | 17 | 17 | 25 | 26 | 5 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
39 | 50 | 18 | 14 | 2 | 0 | 2 | 6 | 5 | 6 | 3 | 2 | 4 | 0 |
Conference proceedings |
0 | 9 | 8 | 0 | 0 | 0 | 21 | 74 | 53 | 0 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
19 | 42 | 46 | 48 | 62 | 45 | 39 | 55 | 73 | 39 | 31 | 6 | 0 | 0 |
| Journal total citations count | 437 |
| Journal impact factor | 1.58 |
| Journal 5 years impact factor | 3.08 |
| Journal cite score | 3.74 |
| Journal h-index | 11 |
| Journal h-index since 2019 | 9 |
Important citations (368)
Safety and rate of delayed adverse events with lumen-apposing metal stents (lams) for pancreatic fluid collections: a multicenter study. |
|
Age-rage synergy influences programmed cell death signaling to promote cancer |
|
the receptor for advanced glycation end products: a fuel to pancreatic cancer. |
|
a high mannose concentration is well tolerated by colorectal adenocarcinoma and melanoma cells but toxic to normal human gingival fibroblast: an in vitro investigation |
|
salmonella-based therapy targeting indoleamine 2,3-dioxygenase restructures the immune contexture to improve checkpoint blockade efficacy. |
|
restructuring of the immune contexture improves checkpoint blockade efficacy in murine lung cancer |
|
the historical elements of cancer permeation in melanoma |
|
exosomes: mediators and therapeutic targets of diabetes and pancreatic cancer |
|
Concise review: current trends on applications of stem cells in diabetic nephropathy |
|
Extracellular nanovesicles: from intercellular messengers to efficient drug delivery systems. |
|
exosomal formulation escalates cellular uptake of honokiol leading to the enhancement of its antitumor efficacy |
|
exosome-mediated delivery of mir-30a sensitize cisplatin-resistant variant of oral squamous carcinoma cells via modulating beclin1 and bcl2 |
|
effects of different separation methods on the physical and functional properties of extracellular vesicles. |
|
platinum-resistant ovarian cancer: from drug resistance mechanisms to liquid biopsy-based biomarkers for disease management. |
|
exosomes potentiate nf-?b signaling, tumor progression, and metastasis in hepatocellular carcinoma |
|
extracellular and intracellular micrornas in pancreatic cancer: from early diagnosis to reducing chemoresistance |
|
diffusion-based separation of extracellular vesicles by nanoporous membrane chip. |
|
tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells |
|
Exosomes in carcinogenesis: molecular palkis carry signals for the regulation of cancer progression and metastasis |
|
protein kinase d1, reduced in human pancreatic tumors, increases secretion of small extracellular vesicles from cancer cells that promote metastasis to lung in mice |
|